ada guidelines dpp4 and glp-1 The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect EASD/ADA 2012 Consensus statement. DPP-4-i,

doi: 10.1152/ajprenal.00339.2006 224 WangMYuanQXieL

NOT FOR USE IN NEONATES LOT #####AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 30 mL Vial Tray 30 mL Multiple-dose NDC 0409-3977-03 Contains 25 of NDC 0409-3977-01 Rx only BACTERIOSTATIC WATER for Injection, USP WARNING: NOT FOR USE IN NEONATES

In murine models, the activation of GLP-1 receptors within the VTA has been shown to attenuate the synaptic strength of the VTA-NAcc pathway, 154 although GLP-1 receptor expression in VTA neurons is relatively sparse

Hypoglycemia , though uncommon with tirzepatide monotherapy, can cause nighttime awakenings, sweating, and restlessness if blood glucose drops too low during sleep